Form 8.3 - Aon plc

Form 8.3 - Aon plc

BARCLAYS PLC

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 23 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

560,321

0.25%

1,736,139

0.77%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

123,157

0.05%

7,125

0.00%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

24,200

0.01%

24,200

0.01%

 

 

 

 

TOTAL:

 

 

 

 

707,678

0.31%

1,767,464

0.78%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

2

231.7400 USD
Purchase

2

231.3250 USD
Purchase

3

231.0466 USD
Purchase

4

231.4950 USD
Purchase

4

231.5100 USD
Purchase

4

231.6300 USD
Purchase

4

231.3350 USD
Purchase

6

231.3900 USD
Purchase

8

231.5550 USD
Purchase

8

230.5950 USD
Purchase

8

231.6150 USD
Purchase

11

231.6281 USD
Purchase

15

231.1800 USD
Purchase

16

231.3750 USD
Purchase

24

231.1900 USD
Purchase

25

231.1760 USD
Purchase

85

231.5300 USD
Purchase

100

231.4600 USD
Purchase

131

231.3149 USD
Purchase

161

230.9800 USD
Purchase

200

231.0550 USD
Purchase

200

231.3450 USD
Purchase

238

230.7599 USD
Purchase

273

230.8920 USD
Purchase

333

231.2733 USD
Purchase

459

231.0976 USD
Purchase

555

231.4888 USD
Purchase

585

231.1710 USD
Purchase

886

230.6685 USD
Purchase

1,125

231.1739 USD
Purchase

1,200

231.3191 USD
Purchase

1,400

231.1978 USD
Purchase

1,718

230.8299 USD
Purchase

2,447

230.8900 USD
Purchase

2,700

231.1751 USD
Purchase

3,461

230.8916 USD
Purchase

5,483

231.1637 USD
Purchase

5,523

231.3223 USD
Purchase

5,725

231.1639 USD
Purchase

6,072

231.3637 USD
Purchase

14,594

230.9285 USD
Purchase

20,161

231.1151 USD
Sale

2

230.7750 USD
Sale

3

231.2100 USD
Sale

8

230.5950 USD
Sale

8

230.7800 USD
Sale

8

231.0300 USD
Sale

10

230.6100 USD
Sale

15

231.1800 USD
Sale

17

230.8050 USD
Sale

20

231.4600 USD
Sale

23

230.8678 USD
Sale

24

230.7116 USD
Sale

26

230.6861 USD
Sale

31

230.7417 USD
Sale

37

230.7828 USD
Sale

42

230.7057 USD
Sale

67

231.3200 USD
Sale

76

231.2969 USD
Sale

82

230.8992 USD
Sale

100

230.5700 USD
Sale

100

230.5800 USD
Sale

100

230.5900 USD
Sale

100

231.1100 USD
Sale

100

231.1669 USD
Sale

100

231.2150 USD
Sale

100

231.3500 USD
Sale

101

231.1300 USD
Sale

169

230.9800 USD
Sale

203

231.3250 USD
Sale

256

230.8978 USD
Sale

300

231.2700 USD
Sale

400

231.3875 USD
Sale

512

231.5300 USD
Sale

886

230.6685 USD
Sale

941

231.2489 USD
Sale

1,086

231.0276 USD
Sale

1,476

230.8595 USD
Sale

1,482

231.1876 USD
Sale

3,317

230.8900 USD
Sale

3,496

230.8986 USD
Sale

4,230

231.1574 USD
Sale

5,624

231.1634 USD
Sale

5,885

231.2095 USD
Sale

18,905

231.0357 USD
Sale

26,423

231.1784 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

26 Apr 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or

Number of

Exercise Type Expiry

purchased

relevant securities

price date

 

to which the option

 

or derivative

 

relates

Put Options

Purchased

-1,200

220.0000

American Jul 16, 2021
Call Options

Purchased

1,200

240.0000

American Jul 16, 2021
Call Options

Purchased

23,000

220.0000

American Jul 16, 2021
Put Options

Purchased

-23,000

200.0000

American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings